Hypoglycemic effect of C. butyricum-pMTL007-GLP-1 engineered probiotics on type 2 diabetes mellitus
Diabetes mellitus (DM) is a complex metabolic disease characterized by hyperglycemia. Recently, the incidence of diabetes has increased exponentially, and it is estimated to become the seventh leading cause of global mortality by 2030. Glucagon-like peptide-1 (GLP-1), a hormone derived from the inte...
Saved in:
| Main Authors: | Dexi Zhou, Shengjie Li, Gang Hu, Yufan Wang, Zhanghua Qi, Xuan Xu, Jing Wei, Qiong Liu, Tingtao Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Gut Microbes |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2024.2447814 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A neonate with meningitis caused by probiotic-related Clostridium butyricum
by: Yanfang Jiang, et al.
Published: (2025-06-01) -
The effect of probiotic (Clostridium butyricum) on adult patients with atopic dermatitis: a retrospective cohort study from TriNetX
by: Kuo-Hsiung Shu, et al.
Published: (2025-09-01) -
Efficacy of <i>Clostridium butyricum</i> Supplementation Combined with Phototherapy for Neonatal Hyperbilirubinemia: A Systematic Review and Meta-Analysis
by: Eun-Jin Kim, et al.
Published: (2025-06-01) -
Probiotic-related bacteremia after major hepatectomy for biliary cancer: a report of two cases
by: Mitsuhiro Shimura, et al.
Published: (2021-06-01) -
Oral Combined Probiotics Clostridium butyricum and Akkermansia muciniphila Inhibits the Progression of 4T1 Breast Cancer by Activating Bcl‐2/Bax Pathway
by: Xiaowei Li, et al.
Published: (2025-06-01)